Back to Journals » OncoTargets and Therapy » Volume 11
Review
Early and late outcomes of bevacizumab plus chemotherapy versus chemotherapy alone as a neoadjuvant treatment in HER2-negative nonmetastatic breast cancer: a meta-analysis of randomized controlled trials
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
7,998 | Dovepress* | 7,614+ | 879 | 8,493 | |
PubMed Central* | 384 | 194 | 578 | ||
Totals | 7,998 | 1,073 | 9,071 | ||
*Since 12 December 2018 |
View citations on PubMed and Google Scholar